Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$672,532
-$373,806 QoQ
Shares Held
412,597
-35.7% QoQ
Ownership
0.454%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $48,167,307,647 across 354 Biotechnology names. CDXS ranks #198 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $672,532 | 412,597 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,046,338 | 641,926 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,425,855 | 584,367 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,249,270 | 4,610,357 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,291,752 | 4,569,425 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $21,591,834 | 4,526,590 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $13,851,036 | 4,497,090 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $13,780,330 | 4,445,268 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $15,473,469 | 4,433,659 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $13,317,769 | 4,366,482 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,194,245 | 4,335,580 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,785,703 | 1,709,180 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,771,831 | 1,635,708 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $7,737,160 | 1,660,335 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,067,723 | 1,826,357 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $18,716,882 | 1,789,377 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $28,535,791 | 1,383,889 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $43,164,764 | 1,380,389 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $32,129,014 | 1,381,299 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $30,025,428 | 1,325,041 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $30,332,476 | 1,325,141 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $36,778,419 | 1,684,765 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $20,036,493 | 1,706,686 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $17,006,656 | 1,491,812 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $16,858,586 | 1,510,626 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||